Results 11 to 20 of about 45,683 (251)

Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors

Preventive Medicine Reports, 2023
People who use drugs (PWUD) are the most directly affected by the overdose epidemic. However, they are not often targets of overdose education and naloxone distribution (OEND) programs.
Michael Enich, Rachel Flumo, Stephanie Campos, Netanya Flores, Nora Sullivan, Jenna Mellor, Caitlin O'Neill, Amesika N. Nyaku   +7 more
doaj   +2 more sources

An experimental study on the role of naloxone in facilitating alcohol metabolism in acute alcohol intoxication rats [PDF]

Future Science OA
Objectives Naloxone has been used in acute alcohol intoxication (AAI) in China and some other Asian countries. However, the effects of naloxone on alcohol metabolism and its mechanisms are unclear.
Ziqi Jin, Yingqi Hu, Xuqi Liu, Yingying Cao, Jiayi Zhang, Runa A, Xiaoxue Wang, Lingyu Zhang, Yongzhi Xue   +8 more
doaj   +2 more sources

Beyond access: improving real-world naloxone use to address the opioid overdose epidemic [PDF]

International Journal of Emergency Medicine
James Neuenschwander, R. Gentry Wilkerson, Scott G. Weiner   +2 more
doaj   +2 more sources

Randomised Trial of Intranasal Versus Intramuscular Naloxone in Prehospital Treatment for Suspected Opioid Overdose

, 2005
Objective: To determine the effectiveness of intranasal (IN) naloxone compared with intramuscular (IM) naloxone for treatment of respiratory depression due to suspected opiate overdose in the prehospital setting.
Kelly, Anne-Maree, Dietze, Paul, Patrick, Ian, Kerr, Debra, Koutsogiannis, Zeff, Walker, Tony   +5 more
core   +6 more sources

Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs

BMC Health Services Research, 2023
Background Opioid overdose fatalities are preventable with timely administration of naloxone, an opioid antagonist, during an opioid overdose event. Syringe service programs have pioneered naloxone distribution for potential bystanders of opioid overdose.
Sheila V. Patel, Lynn D. Wenger, Alex H. Kral, Kenneth Sherr, Anjuli D. Wagner, Peter J. Davidson, Barrot H. Lambdin   +6 more
doaj   +1 more source

Practical implications of naloxone knowledge among suburban people who use opioids

Harm Reduction Journal, 2021
Background Naloxone distribution programs have been a cornerstone of the public health response to the overdose crisis in the USA. Yet people who use opioids (PWUO) continue to face a number of barriers accessing naloxone, including not knowing where it ...
Kristin E. Schneider, Glenna J. Urquhart, Saba Rouhani, Ju Nyeong Park, Miles Morris, Sean T. Allen, Susan G. Sherman   +6 more
doaj   +1 more source

Pharmacy Students’ Perceptions and Stigma Surrounding Naloxone Use in Patients with Opioid Use Disorder: A Mixed Methods Evaluation

Pharmacy, 2020
Pharmacists represent a key group of healthcare professionals that can increase awareness and destigmatize naloxone use. The objective of this study was to investigate pharmacy student perceptions of the use, dispensing, and stigma surrounding naloxone ...
Alina Cernasev, Michael P. Veve, Taylor Talbott, Elizabeth A. Hall, Kenneth C. Hohmeier   +4 more
doaj   +1 more source

Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment

Harm Reduction Journal, 2023
Background Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in ...
Zofia Kozak, Daniel Ciccarone, Johannes Thrul, Thomas O. Cole, Alexander L. Pappas, Aaron D. Greenblatt, Christopher Welsh, Mark Yoon, Donald Gann, E. Erin Artigiani, Eric D. Wish, Annabelle M. Belcher   +11 more
doaj   +1 more source

Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study.

PLoS ONE, 2021
IntroductionTake-Home Naloxone programs have been introduced across North America in response to rising opioid overdose deaths. There is currently limited real-world data on bystander naloxone administration, overdose outcomes, and evidence related to ...
Amina Moustaqim-Barrette, Kristi Papamihali, Sierra Williams, Max Ferguson, Jessica Moe, Roy Purssell, Jane A Buxton   +6 more
doaj   +2 more sources

Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another

Pharmacy, 2021
A recent report found that the number of opioid-related deaths in Ontario in the first 15 weeks of the COVID-19 pandemic was 38.2% higher than in the 15 weeks before the pandemic.
George Daskalakis, Ashley Cid, Kelly Grindrod, Michael A. Beazely   +3 more
doaj   +1 more source